Washington, DC/--°
Updating
Subscribe free
National Sports

Jalen Hurts is out for the season after blood clots spread to both lungs

The Philadelphia Eagles confirmed Monday that Hurts has deep vein thrombosis and bilateral pulmonary emboli, a serious diagnosis that ends his 2026 campaign and leaves Tanner McKee as the starter for a team that was already reeling at 2-3.

From a cleat to the calf to blood clots in both lungs: Hurts is done for 2026

It started with a cleat. It ended with a quarterback's season.

On Monday morning, the Philadelphia Eagles and Hurts' agent, Nicole Lynn, released a joint statement confirming that doctors had found multiple blood clots in the quarterback's lungs. Hurts is expected to miss the rest of the 2026 season, with sources telling both NFL Network's Ian Rapoport and ESPN's Adam Schefter that the treatment involving blood thinners is expected to sideline the three-time Pro Bowler for at least three months.

Lynn and the Eagles said Hurts has deep vein thrombosis and bilateral pulmonary emboli, meaning a blood clot traveled from his leg to his lungs. Both lungs. A diagnosis of bilateral pulmonary emboli means there are clots on both his right and left lungs, a condition that can cause permanent lung damage, low blood oxygen levels, and damage to other organs.

The Eagles traced the whole thing back to a Week 4 loss to the Los Angeles Rams. Hurts was initially diagnosed with a blood clot in his calf last Saturday in London. He had reported to the team after practice on Thursday, Oct. 8 that he had taken a cleat to the calf in that Week 4 defeat, then practiced in full the next day and flew with the team to London overnight.

A "superficial blood clot" turned up during an evaluation on Saturday in London, but the Eagles said medical staff and doctors determined that Hurts could safely play. A subsequent follow-up exam on Wednesday "revealed movement in the small blood clot," which set off the chain of events that led to this week's announcement.

The Eagles placed him on injured reserve Saturday. Then, two days later, the full picture got worse. The Eagles and Lynn released a statement relaying that doctors had discovered multiple blood clots in his lungs. Hurts is now expected to miss the remainder of the 2026 season as he undergoes treatment, with his recovery projected to take three months.

The team called his prognosis "very good." The Eagles said they expect a full recovery, anticipating that Hurts "will have the opportunity to resume contact football activities when off the blood thinners," and that they expect "no long-term effects." That's genuinely good news for Hurts the person. For the Eagles the football team, the hole is enormous.

A 2-3 team now hands the keys to Tanner McKee

Hurts' injury is serious and could make McKee the starter for the rest of the regular season. The Eagles are 2-3 and had already lost three consecutive games headed into Week 6. Now they need Tanner McKee to keep them in the playoff picture, possibly for the next three months.

McKee, 26, is a Stanford product and a 2023 sixth-round pick. He has started two games in his career, both in Week 18 in back-to-back seasons when the Eagles had already clinched their playoff seeds and decided to rest Hurts. He has never played a snap outside garbage time in a meaningful regular-season game.

That changes now. McKee addressed the moment Thursday after it first became clear Hurts was out for at least one game. "As a backup quarterback, that's the mindset you have to have," he said. "At any moment, you have to be ready to play on a Sunday. It could be the first play, it could be the last play. It's kind of a luxury for me to have the '1' reps in practice ... It's kind of a luxury for me as a backup to have a week to prepare like that."

The Eagles did try to trade McKee this past offseason. The team reportedly spent most of the offseason entertaining trade offers for him. No team met their asking price. Given what's unfolding, Howie Roseman will take that outcome.

McKee started the Week 6 game against Carolina before the full scope of Hurts' diagnosis was made public. Monday Night Football then showed the broader damage, as the San Francisco 49ers beat the Washington Commanders 23-17. Philadelphia's schedule does not get easier. The Eagles still face divisional opponents who know their personnel cold, and McKee has logged fewer than 100 career dropbacks.

What this means for the NFC East

The Eagles entered 2026 as defending Super Bowl champions. Losing Hurts this early in the season is the kind of injury that reshapes a conference. Philadelphia had already been outscored and outplayed during their three-game skid before any of this happened. Now the NFC East competition, the Cowboys, Giants, and Commanders, all get to play the next several weeks against a backup making his first meaningful regular-season starts.

Hurts was initially diagnosed by specialists in London with a left calf superficial vein thrombosis. After further testing and monitoring, the updated diagnosis is deep vein thrombosis, as well as bilateral pulmonary emboli. He is clinically stable and has no significant functional limitations. The Eagles said he will remain active around the team and continue to condition while on anticoagulation medication.

The medical picture, at least, points toward a healthy offseason return. Philadelphia's 2026 season is a different story. McKee is in the final year of his four-year, $4.02 million rookie contract, which means he's also playing for his next deal in a situation most quarterbacks never asked for. If he struggles, the Eagles' front office may look at the trade market before the deadline. If he holds the line, he earns a payday. Either way, the next month of NFC East football just got a lot more unpredictable.

The Eagles' next game, and McKee's first full week of preparation as the unambiguous starter, is Sunday.

Sources